One of the approaches to increase bioavailability of resveratrol is to protect its 3-OH phenolic group. In this work, regioselective acylation of resveratrol at 3-OH was achieved by transesterification with vinyl acetate catalyzed by immobilized lipase from Alcaligenes sp.
INTRODUCTION
Antioxidants protect cells against the effects of harmful free radicals and play an important role in preventing many human diseases (e.g., cancer, atherosclerosis, stroke, rheumatoid arthritis, neurodegeneration, inflammatory disorders, diabetes) and aging itself (1) (2) (3) (4) . The study of antioxidants is of great interest for the role they play in protecting living systems against lipid peroxidation and other anomalous molecular modifications (5) (6) (7) . The modification of natural antioxidants to improve their chemical, oxidative or thermal stability, bioavailability and/or pharmaceutical efficacy yields a series of "semisynthetic" antioxidants (e.g., tocopheryl acetate, L-ascorbyl palmitate) with great impact in the industry (8, 9) .
Resveratrol (trans-3,5,4'-trihydroxystilbene) (1) is a polyphenolic phytochemical found in grapes and many plants (10) that is biosynthesized in response to pathogenic attack or stress conditions. It possesses a variety of antioxidant (6) , anti-inflammatory (11, 12) , antitumour (13, 14) cardioprotective (15) , neuroprotective (16) and immunomodulatory (17) bioactivities, as well as a delaying effect on aging (18) . As phenolic compound, resveratrol contributes to the antioxidant potential of red wine (19) and may be related with the decrease in coronary heart disease observed among wine drinkers (French paradox). At present, resveratrol is under Phase-II clinical trials for the prevention of colon cancer (4) .
It has been well reported that minimal chemical modification on the stilbene nucleus may cause large variations in the biological activity and, more specifically, in the antitumour properties of resveratrol (16, (20) (21) (22) . Lipophylic derivatives of resveratrol, and in particular esters bearing acyl chains, may be important in view of their enhanced affinity with lipophylic membrane constituents, thus increasing their bioavailability (23) . Some acylated derivatives have shown higher cell-growth inhibition towards DU-145 human prostate cancer cells than resveratrol itself (20) .
A reported problem with resveratrol is its limited bioavailability owing to its fast metabolism in the liver yielding the less-active 3-sulfate and 3-glucuronide derivatives (24) . As a consequence, the circulating resveratrol has a serum half-life of 8-14 min (25) . One of the approaches to increase bioavailability is to obtain resveratrol analogues or derivatives with comparable activity that cannot be sulfated or glucuronated. For that reason, the regioselective modification of the 3-OH is of great interest (24) .
As the phenolic groups of resveratrol at positions 3-and 4'-exhibit very similar reactivity (the phenolic groups at 3-and 5-are chemically equivalent, as resveratrol is a symmetric molecule), the extraordinary selectivity of enzymes (26) is being exploited for its regiospecific acylation (20) , oxidation (27) or glycosylation (28) . Thus, acylation of resveratrol by Candida antarctica lipase B with vinyl acetate afforded regioselectively 4'-O-acetyl-resveratrol (20, 29, 30) ; however, reactions with longer acyl donors such as vinyl decanoate and vinyl cinnamoate were notably slower.
Regioselective derivatization of resveratrol at positions 3,5-was achieved by a chemo-enzymatic procedure based on standard chemical peracetylation followed by lipase-catalyzed alcoholysis of 4'-acyl group in organic solvents (30) .
As part of our interest in regioselective biotransformations of polyhydroxylated compounds (31) (32) (33) (34) using immobilized enzymes (35, 36) , we have investigated the one-step enzymatic synthesis of acylated resveratrol by lipase-catalyzed transesterification. Our results suggest that the regioselectivity of the process can be controlled by an adequate selection of the biocatalyst (37).
MATERIALS AND METHODS

Materials
Resveratrol from Polygonum cuspidatum was purchased in Shanghai Seebio Biotechnology. Tripropionin was from Acros. Vinyl acetate, 2-methyl-2-butanol (t-amyl alcohol), α-tocopherol, Trolox (6-hydroxy-2,5,7,8-tetramethychroman-2-carboxylic acid), ABTS (2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonate) and potassium persulfate were purchased from Sigma-Aldrich.
Vinyl stearate was from TCI-Europe. Vinyl oleate was from ABCR GmbH & Co (Germany). Solvents were dried over 3 Å molecular sieves (water content was less than 0.2% v/v by Karl-Fischer). All other reagents were of the highest available purity and used as purchased.
Determination of enzyme activity
The hydrolytic activity was measured titrimetrically at pH 8.0 and 30 °C using a pH-stat (Mettler, Model DL 50). The reaction mixture contained tripropionin (0.3 ml, final concentration 80 mM), acetonitrile (0.7 ml) and Tris-HCl buffer (19 ml, 1 mM, pH 8.0) containing NaCl (0.1 M). The immobilized biocatalyst was then added and the pH automatically maintained at 8.0 using 0.1 N NaOH as titrant. Experiments were done in triplicate. One enzyme unit (U) was defined as that catalyzing the formation of 1 µmol of fatty acid per min.
General procedure for enzymatic reactions on analytical scale
Resveratrol (59.2 mg, 50 mM) and vinyl acetate (0.345 ml, 750 mM) or vinyl stearate (1.16 g, 750 mM) were incubated in 2-methyl-2-butanol (5 ml) in sealed 30 ml dark vials under nitrogen at 40 °C with 150 rpm orbital shaking (SI50, Stuart Scientific). The biocatalyst was added to a final concentration of 150 mg/ml. Aliquots (200 μl) were withdrawn at intervals, filtered using an Eppendorf tube containing a Durapore ® 0.45μm filter and the progress of the reaction analyzed by HPLC.
Preparative-scale enzymatic reactions
The reaction mixture contained resveratrol (570 mg, 250 mM), vinyl acetate (3.45 ml, 3.75 M), lipase QLG (1.5 g) and 2-methyl-2-butanol (6.55 ml). The mixture was incubated under similar conditions to those described in the analytical scale procedure and monitored by HPLC. After 30 h, the mixture was cooled, filtered, the solvent evaporated and the crude preparation loaded onto a silica-gel column using 
HPLC/MS
Samples were analyzed by HPLC (model 1100, Agilent Technologies) coupled to a mass spectrometer (model QSTAR pulsar, Applied Biosystems). Chromatographic conditions were as described above, except for the mobile phase that contained 1% (v/v) formic acid and the flow rate was lowered to 0.6 ml/min. Ionization was performed by electrospray and the mass spectrometer had a hybrid QTOF analyzer.
Nuclear Magnetic Resonance (NMR)
NMR spectra of the different compounds were recorded on a Bruker DRX 500 spectrometer using DMSO as solvent. A temperature of 298 K was employed with concentrations around 10 mM.
Chemical shifts were reported in ppm, and referenced versus the solvent signal. Vicinal proton-proton coupling constants were estimated from first order analysis of the spectra. The 2D-TOCSY experiment (60 ms mixing time) was performed using a data matrix of 256×1K to digitize a spectral width of 5000
Hz. Four scans were used per increment, with a relaxation delay of 2 s. 2D-NOESY (600 ms) and 2D-T-ROESY experiments (500 ms) used the standard sequences provided by the manufacturer, and the data matrixes described above, with 32 and 48 scans per increment, respectively. In all cases, squared cosine-bell apodization functions were applied in both dimensions. The spectral widths for the HSQC spectra were 5000 Hz and 18000 Hz for the 1H and 13C-dimensions, respectively. The number of collected complex points was 1028 for the 1H-dimension with a recycle delay of 2 s. The number of transients was 16, and 256 time increments were always recorded in the 13C-dimension. The Jcoupling evolution delay was set to 3.2 ms. A squared cosine-bell apodization function was applied in both dimensions. Prior to Fourier transform the data matrixes were zero filled up to 1024 points in the 13C-dimension. The spectral widths for the HMBC spectra were 5000 Hz and 25000 Hz for the 1H and 13C-dimensions, respectively. The number of collected complex points was 1028 for the 1H-dimension with a recycle delay of 2 s. The number of transients was 64, and 256 time increments were always recorded in the 13C-dimension. The J-coupling evolution delay was set to 66 ms. Prior to Fourier transform the data matrixes were zero filled up to 1024 points in the 13C-dimension.
TEAC assay
To measure the antioxidant activity of the new compounds we used the Trolox Equivalent Antioxidant Capability (TEAC) assay that was previously described by Re et al. (38) , with some modifications to adapt to 96 well plates. This assay is based on the ability of antioxidants in reducing ABTS radical.
Briefly, ABTS (7 mM final concentration) was added to an aqueous solution of 2.45 mM potassium persulfate and kept in the dark at room temperature for 15 h to obtain the ABTS radical, which was stable for 2 days. The ABTS 
RESULTS AND DISCUSSION
Enzyme screening for acetylation of resveratrol
Several lipases and esterases were used for a preliminary HPLC screening of acetylation of resveratrol (1) in 2-methyl-2-butanol (2M2B) under the following conditions: 50 mM resveratrol, 750 mM vinyl acetate, 100 mg/ml biocatalyst and 40 °C. The solvent 2M2B was selected for the screening due to the notable solubility of resveratrol and vinyl acetate. Six commercial immobilized lipases were found to catalyse this process (Table 1) . Two peaks (corresponding to compounds 2 and 3) were observed in the monoester fraction of the HPLC chromatograms (Fig. 1) , as well as two peaks corresponding to the The use of lipase QLG initially leads to one compound that has a non-symmetric spectrum in ring A (the three substituted one, Fig. 2 ). It has to be mentioned that resveratrol shows a symmetric spectrum for both rings. One acetate group was clearly visible in the spectra with two free hydroxyl groups, one for ring A and one for ring B. The existence of mono acetyl substitution was also confirmed by MS analysis. NOESY spectra showed contacts between the acetate group and hydrogens H2 and H4 Considering that the positions of the phenolic substituents on the aromatic rings of resveratrol may play an important role in its biological activity (43) , and that protection of 3-OH is one of the approaches to improve resveratrol bioavailability, we focused our attention towards lipase QLG as a simple and selective alternative to obtain monoesters at 3-OH. This biocatalyst is obtained by immobilising a lipase from Alcaligenes sp. (MW 31,000) on granulated diatomaceous earth. We observed by scanning electron microscopy (SEM) that the particle size was quite uniform for this biocatalyst (approx. 500 µm) (see Supporting Information). Up to now, the main application of this immobilized lipase has been the resolution of racemic mixtures (44) . (2) was synthesized, whereas the formation of diester 5 was almost negligible. The maximum yield of monoester with lipase QLG reached nearly 75% (on a molar basis) in 12 h, whereas for the diester 5
Kinetics of resveratrol acetylation
the maximum yield (approx. 60%) was achieved at 160 h. With Novozym 435 a maximum yield of 80% for monoester 2 was obtained in 50 h.
Resveratrol acylation with vinyl stearate
We tested the acylation of resveratrol with saturated and unsaturated long-chain acyl-donors. The monoester selectivity was similar to that observed in the acetylation process. Fig. 4 shows the HPLC chromatograms with lipases from Alcaligenes sp. (lipase QLG), P. cepacia (lipase PS IM) and T.
lanuginosus (Lipozyme TL IM) in the transesterification with vinyl stearate. As shown in Fig. 4 , the acylation with vinyl stearate catalyzed by lipase QLG afforded one major compound (7). The NMR and MS spectra showed that this was a mono-substituted molecule, whose HMBC spectrum was indeed similar to that of compound 3. The careful HMBC analysis suggested that this molecule was 3-O-stearoyl-resveratrol (7), which was further confirmed by the existence of NOE contacts and spatial proximity between the CH2 moiety of the fatty acid chain and hydrogens H-2 and H-4 at the aromatic ring A. Thus, the nature of 7 was unequivocally confirmed. Novozym 435 also formed a monosubstituted major compound, whose NMR spectra were different to those of monostearate 7. The spectra showed symmetry for both rings, and the HMBC and NOESY analysis (NOEs between the CH2 moiety of the fatty acid chain and hydrogens H-3' and H-5' at the aromatic ring B) indicated that this molecule was 4'-O-stearoyl-resveratrol (8).
The highest selectivity towards the monoester 3-O-stearoyl-resveratrol (7) was obtained again with lipase QLG, whereas PS IM and TL IM yield mixtures of the two isomers with the 3-derivative as the major product. We observed that lipase QLG also afforded regioselectively derivatives at 3-OH bearing unsaturated fatty acids (e.g., oleic acid, data not shown). Lipases PLG and RM IM afforded mixtures of 3-and 4'-regioisomers, with a major content in 4'-isomer. 
Antioxidant Activity
The antioxidant activity of the new derivatives was analyzed. We initially compared the antioxidant capability of resveratrol with other phenolic antioxidants such as α-tocopherol and Trolox (used as standard). Fig. 6 shows a different behavior between resveratrol and α-tocopherol. The latter was able to complete the reaction in 1 min; in contrast, resveratrol showed a further small inhibitory effect even after 7 min reaction. Resveratrol showed also a higher activity than Trolox and α-tocopherol, which may be related to the fact that resveratrol has three hydroxyl groups (hydrogen donors) whereas α-tocopherol and Trolox present only one (6) .
The new acetyl derivatives showed antioxidant activity but it decreased when increasing the degree of substitution of the phenolic groups. The results of the assay are presented in Fig. 7 and the TEAC values are summarized in Table 2 . We observed that the addition of an acyl chain in the position 3-OH caused a higher loss of activity compared with the 4'-OH; the TEAC value for the acetyl derivative at 3-OH was 40% that of resveratrol. Thus, 3-OH seems to play an important role in antioxidant activity.
Stivala et al. reported that the hydroxyl group in the 4'-position is required for the antioxidant activity (45) . It is noteworthy that the ethanolic solution of resveratrol and the 4'-OH derivatives developed a yellow color (typical of resveratrol oxidation) during the assay, which was not observed with the monoesters at 3-OH; this observation may be related with the intrinsic stability of the different compounds. Regarding the stearoyl derivatives (Fig. 8) , the effect of chemical modification of aromatic rings on the antioxidant activity was more pronounced than in the acetylation. Again, the substitution at 3-OH gave rise to a higher decrease of activity than the corresponding at 4'-OH. 
CONCLUSIONS
